List | Section | Observation |
---|---|---|
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 03.04. ANTIVIRALES | No observations |
List | Section | Observation |
---|---|---|
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Anti-Retroviral Treatment Programme | No observations |
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 07.07 ANTIVIRALS | No observations |
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | J. ANTI-INFECCIOSOS PARA USO SISTEMICO | No observations |
Paraguay. Lista de Medicamentos Esenciales. 2009 | 05. ANTIVIRALES DE USO SISTÉMICO | No observations |
Cayman Islands Health Services Authority Pharmacy Drug Formulary | 05.03.03 Protease Inhibitors | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.2.3. Protease inhibitors |
Age or weight restriction:
>3 years |
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Anti-Retroviral Treatment Programme | No observations |
Costa Rica. Caja Costarricense de Seguro Social. 2019 | 04. Antifungicos y Antivirales |
Others observations: Como etanoato. Tabletas recubiertas. |
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: FCO X 60 TAB |
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 07.07 ANTIVIRALS | No observations |
Mexico. Cuadro Basico de Medicamentos - 2017 | 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS | No observations |
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | J. ANTI-INFECCIOSOS PARA USO SISTEMICO | No observations |
El Salvador - 2019 | ANTIVIRALES DE USO SISTÉMICO | No observations |
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 8:18 Antiretroviral Agents | No observations |
Haiti. National List of Essential Medicines | 06.04.02.03 Protease inhibitors (PIs) | No observations |
List | Section | Observation |
---|---|---|
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 07.07 ANTIVIRALS | No observations |
Mexico. Cuadro Basico de Medicamentos - 2017 | 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS | No observations |
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | J. ANTI-INFECCIOSOS PARA USO SISTEMICO | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.2.3. Protease inhibitors |
Age or weight restriction:
>3 years |
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |
Haiti. National List of Essential Medicines | 06.04.02.03 Protease inhibitors (PIs) | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.2.3. Protease inhibitors |
Age or weight restriction:
>3 years |
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |
Mexico. Cuadro Basico de Medicamentos - 2017 | 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS | No observations |
Haiti. National List of Essential Medicines | 06.04.02.03 Protease inhibitors (PIs) | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.2.3. Protease inhibitors |
Age or weight restriction:
>3 years |
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |
Mexico. Cuadro Basico de Medicamentos - 2017 | 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS | No observations |
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | J. ANTI-INFECCIOSOS PARA USO SISTEMICO | No observations |
Haiti. National List of Essential Medicines | 06.04.02.03 Protease inhibitors (PIs) | No observations |